ArticleFrontiers in immunology2020

Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.

Nicolai Grønne Jørgensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.